Home › Ulcerative Colitis › Texas › Arlington
Ulcerative Colitis clinical trials in Arlington, TX
4 studies for Ulcerative Colitis are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- Site US-017, Mansfield · 12 mi away
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RecruitingPhase 2
- GI Alliance - Mansfield /ID# 283924, Mansfield · 12 mi away
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RecruitingPhase 2
- GI Alliance: Mansfield, Mansfield · 12 mi away
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
RecruitingPhase 4
- GI Alliance - Mansfield, Mansfield · 12 mi away
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- New York City, NY24 studies
- Orlando, FL23 studies
- Miami, FL22 studies
- Houston, TX18 studies
- San Antonio, TX16 studies
- San Diego, CA16 studies
- Tacoma, WA15 studies
- Chicago, IL15 studies
- Tyler, TX14 studies
- St. Louis, MO14 studies
- Colorado Springs, CO14 studies
- Los Angeles, CA13 studies
Other studies in Arlington
- Crohn's Disease5 studies
- Psoriatic Arthritis4 studies
- Sjogren's Syndrome4 studies
- Chronic Kidney Disease4 studies
- Lupus4 studies
- Atopic Dermatitis (Eczema)4 studies
- Rheumatoid Arthritis4 studies
- Non-Small Cell Lung Cancer4 studies
- Steatotic Liver Disease4 studies
- Overactive Bladder3 studies
- Non-Muscle Invasive Bladder Cancer3 studies
- High Blood Pressure3 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.